ALIMERA SCIENCES, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 220 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-05-17: Reporting owner Morgan Adam; Form 4; Security Series B Convertible Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2023-05-17: Reporting owner Morgan Adam; Form 4; Security Series B Convertible Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | Morgan Adam Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · By Velan Capital Master Fund LP | P Open market or private purchase of non-derivative or derivative security | +8,117 8,117 owned after | $1.70 exercise price | 2023-05-19 | |
| 2023-05-17 | Morgan Adam Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · By Velan Capital SPV I LLC | P Open market or private purchase of non-derivative or derivative security | +7,000 7,000 owned after | $1.70 exercise price | 2023-05-19 |